Clinical Trials Browser

OTHER_GOV × Bevacizumab × Breast × Clear all

NCT05769010 2024-10-09

Study of SHR-A1811 in HER2-expression Advanced Breast Cancer with Brain Metastases

Phase 2 Recruiting

Breast Neoplasms

NCT05357417 2022-09-16

Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain Metastases

Phase 2 Unknown

Breast Neoplasms

NCT05398861 2022-06-01

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

Phase 2 Unknown

HER-2 Negative Breast Cancer